Apimeds Pharmaceuticals US, Inc.

APUS·NYSE American·Healthcare
Compare
2.9200−0.0500 (−1.68%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.9700
Open2.9800
Day range2.75412.9700
52-week range1.510059.7000
Off day high−1.68%
Off 52-week high−95.11%
Volume11.19K
Avg. volume (3M)3.76M
Market cap4.41M
EPS (TTM)-36.03
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding1.51M
Short interest9.06% of float
Earnings date—
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
APUS INM LABS.TO SHPH ASTRAZEN.BO DMP.F
Market cap 4.41M 9.61M 29.90M 24.82M — 1.93B
P/E (TTM) — — — — 95.1 14.1
Forward P/E — -0.3 -7.0 — — 13.1
Price/book 4.5 0.9 0.8 0.3 18.4 3.6
Dividend yield — — — — 0.57% 2.26%
1-year change −89.16% −2.89% −14.29% −80.71% −30.91% +18.72%
Today −1.68% +4.17% +16.67% +1.17% +1.01% +1.17%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All APUS news ›

From the 4Search news index, newest first.

In the news

2mentions in 30 days
2with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance